Search Results - "Geenen, Laurie W."

The prevalence of pulmonary arterial hypertension before and after atrial septal defect closure at adult age: A systematic review by Zwijnenburg, Roxanne D., Baggen, Vivan J.M., Geenen, Laurie W., Voigt, Kelly R., Roos-Hesselink, Jolien W., van den Bosch, Annemien E.

“…The development or persistence of pulmonary arterial hypertension (PAH) after atrial septal defect (ASD) closure at adult age is associated with a poor…”
Get full text

Kynurenine metabolites predict survival in pulmonary arterial hypertension: A role for IL-6/IL-6Rα by Cai, Zongye, Tian, Siyu, Klein, Theo, Tu, Ly, Geenen, Laurie W., Koudstaal, Thomas, van den Bosch, Annemien E., de Rijke, Yolanda B., Reiss, Irwin K. M., Boersma, Eric, van der Ley, Claude, Van Faassen, Martijn, Kema, Ido, Duncker, Dirk J., Boomars, Karin A., Tran-Lundmark, Karin, Guignabert, Christophe, Merkus, Daphne

“…Activation of the kynurenine pathway (KP) has been reported in patients with pulmonary arterial hypertension (PAH) undergoing PAH therapy. We aimed to…”
Get full text

Exploring the Prognostic Value of Novel Markers in Adults With a Systemic Right Ventricle by Geenen, Laurie W, van Grootel, Roderick W J, Akman, Korhan, Baggen, Vivan J M, Menting, Myrthe E, Eindhoven, Jannet A, Cuypers, Judith A A E, Boersma, Eric, van den Bosch, Annemien E, Roos-Hesselink, Jolien W

“…Background Adults with a systemic right ventricle (sRV) have a high risk of cardiac complications. This study aimed to identify prognostic markers in adults…”
Get full text

Blood Biomarkers Predict 10-Year Clinical Outcomes in Adult Patients With Congenital Heart Disease by Hendriks, Paul M., van den Bosch, Annemien E., Geenen, Laurie W., Baggen, Vivan J.M., Eindhoven, Jannet A., Kauling, Robert M., Cuypers, Judith A.A.E., Boersma, Eric, Roos-Hesselink, Jolien W.

“…The adult congenital heart disease (ACHD) population is growing and risk prediction is important to predict adverse outcome and consult patients during their…”
Get full text

Residual Pulmonary Hypertension more than 20 Years after Repair of Shunt Lesions by Jančauskaitė, Dovilė, Rudienė, Virginija, Jakutis, Gabrielius, Geenen, Laurie W, Roos-Hesselink, Jolien W, Gumbienė, Lina

“…After successful surgical repair of a congenital shunt lesion, pulmonary hypertension (PH) often disappears. However, PH can persist long-term after the…”
Get full text

Blood and imaging biomarkers in the long-term follow-up of bicuspid aortic valve patients by Keuning, Zoë A., Hendriks, Paul M., Duijnhouwer, Anthonie L., Meccanici, Frederike, Siebelink, Hans-Marc J., van den Hoven, Allard T., Geenen, Laurie W., Eindhoven, Jannet A., Baggen, Vivan J.M., Cuypers, Judith A.A.E., Kauling, Robert M., Roos-Hesselink, Jolien W., van den Bosch, Annemien E.

“…Bicuspid aortic valve (BAV) is a common congenital heart defect. Patients with BAV are at risk for long-term complications such as valve stenosis and…”
Get full text

Blood biomarkers in patients with bicuspid aortic valve disease by Bons, Lidia R., Geenen, Laurie W., van den Hoven, Allard T., Dik, Willem A., van den Bosch, Annemien E., Duijnhouwer, Anthonie L., Siebelink, Hans-Marc J., Budde, Ricardo P.J., Boersma, Eric, Wessels, Marja W., van de Laar, Ingrid M.B.H., DeRuiter, Marco C., Goumans, Marie-José, Loeys, Bart L., Roos-Hesselink, Jolien W.

“…•A substantial number of patients with bicuspid aortic valve (BAV) have elevated levels of NT-proBNP, hsTnT, and hs-CRP.•Higher NT-proBNP is associated with…”
Get full text

Evolution of blood biomarker levels following percutaneous atrial septal defect closure in adults by Geenen, Laurie W., Uchoa de Assis, Lucas, Baggen, Vivan J.M., Eindhoven, Jannet A., Cuypers, J.A.A.E., Boersma, Eric, Roos-Hesselink, Jolien W., van den Bosch, Annemien E.

“…•A substantial number of adults with unrepaired ASD have elevated biomarker levels.•Percutaneous ASD closure in adults leads to acute changes in most biomarker…”
Get full text

Role of the electrocardiogram in the risk stratification of pulmonary hypertension by Hendriks, Paul M, Kauling, Robert M, Geenen, Laurie W, Eindhoven, Jannet A, Roos-Hesselink, Jolien W, Boomars, Karin A, van den Bosch, Annemien E

“…The prognosis of pulmonary arterial hypertension (PAH) and chronic thromboembolic pulmonary hypertension (CTEPH) remains dismal. Better risk prediction is…”
Get more information

The prognostic value of various biomarkers in adults with pulmonary hypertension; a multi-biomarker approach by Geenen, Laurie W., Baggen, Vivan J.M., Koudstaal, Thomas, Boomars, Karin A., Eindhoven, Jannet A., Boersma, Eric, Roos-Hesselink, Jolien W., van den Bosch, Annemien E.

“…This study aimed to investigate the prognostic value of six different biomarkers in patients with pulmonary hypertension (PH) and to explore whether a…”
Get full text

Prognostic value of soluble ST2 in adults with congenital heart disease by Geenen, Laurie W, Baggen, Vivan J M, van den Bosch, Annemien E, Eindhoven, Jannet A, Cuypers, Judith A A E, Witsenburg, Maarten, Boersma, Eric, Roos-Hesselink, Jolien W

“…Soluble suppression of tumourigenicity-2 (sST2) is upregulated as response to myocardial stress and may be a potential biomarker for risk stratification in…”
Get more information

Novel biomarkers associated with thoracic aortic disease by Thijssen, Carlijn G.E., Dekker, Silvy, Bons, Lidia R., Geenen, Laurie W., Gökalp, Arjen L., Takkenberg, Johanna J.M., Mokhles, Mostafa M., Bekkers, Jos A., Boersma, Eric, Bouwens, Elke, van Kimmenade, Roland R.J., Roos-Hesselink, Jolien W.

“…Biomarkers might help to improve diagnosis, surveillance and risk stratification of thoracic aortic disease (TAD). We explored the association between a broad…”
Get full text

Reply to letter to the editor: "Novel biomarkers associated with thoracic aortic disease" by Thijssen, Carlijn G E, Dekker, Silvy, Bons, Lidia R, Geenen, Laurie W, Gökalp, Arjen L, Takkenberg, Johanna J M, Mokhles, Mostafa M, Bekkers, Jos A, Boersma, Eric, Bouwens, Elke, van Kimmenade, Roland R J, Roos-Hesselink, Jolien W

Get full text

Heart rate: an accessible risk indicator in adult congenital heart disease by Hendriks, Paul M, van den Bosch, Annemien E, Kors, Jan A, Geenen, Laurie W, Baggen, Vivan J M, Eindhoven, Jannet A, Kauling, Robert M, Cuypers, Judith A A E, Boersma, Eric, Roos-Hesselink, Jolien W

“…Higher resting heart rate has been described as a risk factor for adverse outcome in healthy individuals and cardiovascular patients. The aim of this study was…”
Get more information

Heart failure in congenital heart disease: management options and clinical challenges by Leusveld, Elsbeth M, Kauling, Robert M, Geenen, Laurie W, Roos-Hesselink, Jolien W

“…The population of adults with congenital heart disease (ACHD) is rapidly expanding and one of the major complications is heart failure. Timely diagnosis and…”
Get more information

Prognostic value of the electrocardiogram in patients with bicuspid aortic valve disease by Hendriks, Paul M., Keuning, Zoë A., Kors, Jan A., van den Hoven, Allard T., Geenen, Laurie W., Eindhoven, Jannet A., Baggen, Vivan J.M., Cuypers, Judith A.A.E., Kauling, Robert M., Roos-Hesselink, Jolien W., van den Bosch, Annemien E.

“…Identifying bicuspid aortic valve (BAV) patients at risk for cardiac events remains challenging and the role of the electrocardiogram (ECG) has not yet been…”
Get full text

Prognostic Value of Serial High-Sensitivity Troponin T Measurements in Adults With Congenital Heart Disease by Geenen, Laurie W., Baggen, Vivan J.M., van den Bosch, Annemien E., Eindhoven, Jannet A., Kauling, Robert M., Cuypers, Judith A.A.E., Roos-Hesselink, Jolien W., Boersma, Eric

“…Single high-sensitivity troponin T (hs-TnT) measurement is predictive of cardiac events in adults with congenital heart disease (ACHD). We aimed to study the…”
Get full text

The Prognostic Value of Soluble ST2 in Adults with Pulmonary Hypertension by Geenen, Laurie W., Baggen, Vivan J. M., Kauling, Robert M., Koudstaal, Thomas, Boomars, Karin A., Boersma, Eric, Roos-Hesselink, Jolien W., van den Bosch, Annemien E.

“…Soluble ST2 (sST2) is upregulated in response to myocardial stress and may serve as biomarker in adults with pulmonary hypertension (PH). This prospective…”
Get full text

Tuning and external validation of an adult congenital heart disease risk prediction model by Geenen, Laurie W, Opotowsky, Alexander R, Lachtrupp, Cara, Baggen, Vivan J M, Brainard, Sarah, Landzberg, Michael J, van Klaveren, David, Lingsma, Hester F, Boersma, Eric, Roos-Hesselink, Jolien W

“…Abstract Aims Adequate risk prediction can optimize the clinical management in adult congenital heart disease (ACHD). We aimed to update and subsequently…”
Get full text

Lower Plasma Melatonin Levels Predict Worse Long-Term Survival in Pulmonary Arterial Hypertension by Cai, Zongye, Klein, Theo, Geenen, Laurie W, Tu, Ly, Tian, Siyu, van den Bosch, Annemien E, de Rijke, Yolanda B, Reiss, Irwin K M, Boersma, Eric, Duncker, Dirk J, Boomars, Karin A, Guignabert, Christophe, Merkus, Daphne

“…Exogenous melatonin has been reported to be beneficial in the treatment of pulmonary hypertension (PH) in animal models. Multiple mechanisms are involved, with…”
Get full text